Literature DB >> 6650752

Surgical therapy of advanced esophageal cancer. A critical appraisal.

B Caracci, P Garvin, D L Kaminski.   

Abstract

Thirty-five patients with advanced esophageal carcinoma underwent esophagogastrectomy. Of these, 13 patients underwent esophagogastrectomy through midline celiotomy and right thoracotomy incisions (Group 1), and 20 patients underwent extrathoracic esophagectomy with either reversed gastric tube (Group 2) or isoperistaltic tube reconstruction (Group 3). Morbidity was significantly greater in patients who underwent extrathoracic esophagectomy due to more severe pulmonary complications and anastomotic fistulas. Because of these complications, a longer interval to solid food ingestion occurred in the extrathoracic esophagectomy group. Long-term survival was not affected by the operative procedure utilized. Extrathoracic esophagectomy with cervical anastomosis is associated with more complications than an intrathoracic anastomosis, resulting in inferior palliation for patients with advanced esophageal carcinoma.

Entities:  

Mesh:

Year:  1983        PMID: 6650752     DOI: 10.1016/0002-9610(83)90322-7

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  4 in total

1.  [Resection of esophageal cancer without thoracotomy by manual dissection and eversion stripping].

Authors:  J M Müller; U Zieren; A S Jerke; C Jacobi; M Adili; H Pichlmaier
Journal:  Langenbecks Arch Chir       Date:  1992

2.  Cancer of the esophagus. The Cleveland Clinic experience.

Authors:  S Galandiuk; R E Hermann; D M Cosgrove; J J Gassman
Journal:  Ann Surg       Date:  1986-01       Impact factor: 12.969

3.  Endoesophageal pull through. A technique for the treatment of cancers of the cardia and lower esophagus.

Authors:  F Saidi
Journal:  Ann Surg       Date:  1988-04       Impact factor: 12.969

4.  Results of esophagogastrectomy for carcinoma in cirrhotic patients. A series of 23 consecutive patients.

Authors:  F Fekete; J Belghiti; D Cherqui; F Langonnet; B Gayet
Journal:  Ann Surg       Date:  1987-07       Impact factor: 12.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.